IFF has agreed to sell its portfolio of botanical extracts, vitamins, minerals and food enhancement activities to SuanNutra of Spain.
The transaction includes operations that generated revenues of approximately $170m in 2025.
The combined manufacturing footprint spans botanical extraction in Spain, Slovenia and Peru and fermentation in the United States.
The merged group will have around 700 employees serving more than 1,200 customers in over 60 countries.
Madrid-based SuanNutra said the acquisition strengthens its ‘Visible Health’ strategy – clinically backed ingredients delivering wellness benefits consumers can see and feel.
“Clinically supported branded ingredients are where this industry is heading – proven actives with the science to stand behind them,” added non-executive chairman Yoni Glickman.
“This expansion puts SuanNutra at the forefront of this transition. The move from artificial colours and preservatives to natural, scientifically substantiated ingredients is reshaping the food and health industries faster than ever.”
The deal is expected to close the sale by the end of the year, subject to regulatory approval.
IFF CEO Erik Fyrwald said the transaction is “another step in optimizing its portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health & Biosciences — where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders”.
